Efficacy of Allogeneic UCMSCs for Treating Large Defects Knee Injury

NCT05016011 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cytopeutics Sdn. Bhd.

Collaborators